The purpose of stability testing data and programs is to ensure a drug product’s safety and efficacy remain within its specifications throughout the shelf-life. To develop suitable analytical methods to detect and quantify degradation products, drug manufacturers should conduct forced-degradation studies.
Anna Thabit-Jones, Stability Manager at PCI Services, recently addressed vital points of the process for stability studies with Meg Rivers in Pharmaceutical Technology.
You can read the full article on the Pharmaceutical Technology Website.
We provide a complete range of Analytical Laboratory Services and we are committed to supporting clients at every stage of the clinical cycle, delivering best-in-class services efficiently and effectively.
Find out more about our Commercial & Pharmaceutical Packaging Technologies.